Investigation of the potential for mutational resistsance to XF-73, retapamulin, mupirocin, fusidic acid, daptomycin, and vancomycin in methicillin-resistant Staphylococcus aureus isolates during a 55-passage study.
Investigation of the potential for mutational resistsance to XF-73, retapamulin, mupirocin, fusidic acid, daptomycin, and vancomycin in methicillin-resistant Staphylococcus aureus isolates during a 55-passage study by Farrell DJ, Robbins M Rhys-Williams and Love WG published in Antimicrob. Agents Chemother. 2011; 55 (3): 1177-1181
In vitro activity of telavancin and comparator antimicrobial agents against a panel of genetically defined staphylococci.
In vitro activity of telavancin and comparator antimicrobial agents against a panel of genetically defined staphylococci. by Farrell DJ, Krause KM and Benton BM published in Diagn. Microbiol. Infect. Dis. 2011; 69 (3): 257-279
In vitro activity and single-step mutational analysis of rifamycin SV tested against enteropathogens associated with traveler’s diarrhea and Clostridium difficile.
In vitro activity and single-step mutational analysis of rifamycin SV tested against enteropathogens associated with traveler’s diarrhea and Clostridium difficile. by Farrrell DJ, Putnam SD Biedenbach DJ, Moro L, Bozzella R, Celasco G and Jones RN published in Antimicrob. Agents Chemother. 2011; 55 (3): 992-996
Early dissemination of NDM-1- and OXA-181-producing Enterobacteriaceae in Indian hospitals: Report from the SENTRY Antimicrobial Surveillance Program, 2006-2007.
Early dissemination of NDM-1- and OXA-181-producing Enterobacteriaceae in Indian hospitals: Report from the SENTRY Antimicrobial Surveillance Program, 2006-2007 by Castanheira M, Deshpande LM, Mathai D, Bell JM, Jones RN and Mendes RE published in Antimicrob. Agents Chemother. 2011; 55 (3): 1274-1278
Comment on: Role of changes in the L3 loop of the active site in the evolution of enzymatic activity of VIM-type metallo-beta-lactamases.
Comment on: Role of changes in the L3 loop of the active site in the evolution of enzymatic activity of VIM-type metallo-beta-lactamases. by Castanheira M, Deshpande LM, Mendes RE, Rodriguez-Noriega E, Jones RN, Morfin-Otero, R published in J. Antimicrob. Chemother. 2011; 66 (3): 684-685
Tigecycline Activity Tested against Commonly Isolated Skin and Skin Structure Infection (CSSSI) Pathogens: 2009 USA Surveillance Results
Tigecycline Activity Tested against Commonly Isolated Skin and Skin Structure Infection (CSSSI) Pathogens: 2009 USA Surveillance Results, Lead author: Sader HS, presented at 12th annual Western Pacific Congress of Chemotherapy and Infectious Diseases, December 2 – 5, 2010, Singapore
Daptomycin Antimicrobial Activity and Spectrum when Tested against Gram-positive Organisms from Australia and New Zealand (2008-2009)
Daptomycin Antimicrobial Activity and Spectrum when Tested against Gram-positive Organisms from Australia and New Zealand (2008-2009), Lead author: Sader HS, presented at 12th annual Western Pacific Congress of Chemotherapy and Infectious Diseases, December 2 – 5, 2010, Singapore
Update on Telavancin Activity Treated Against a Global Collection of Gram-positive Pathogens (2009)
Update on Telavancin Activity Treated Against a Global Collection of Gram-positive Pathogens (2009), Lead author: Jones RN, presented at 12th annual Western Pacific Congress of Chemotherapy and Infectious Diseases, December 2 – 5, 2010, Singapore
Candida Bloodstream Infection (CBI): Comparison of Species Distribution and Antifungal Resistance Patterns in Community Onset (CO) and Nosocomial (NOS) CBI Isolates
Candida Bloodstream Infection (CBI): Comparison of Species Distribution and Antifungal Resistance Patterns in Community Onset (CO) and Nosocomial (NOS) CBI Isolates, Lead author: Jones RN, presented at 12th annual Western Pacific Congress of Chemotherapy and Infectious Diseases, December 2 – 5, 2010, Singapore
Variation of Species Distribution and Antifungal Resistance (R) Among Candida Bloodstream Infection (CBI) Isolates in Four Geographic Regions
Variation of Species Distribution and Antifungal Resistance (R) Among Candida Bloodstream Infection (CBI) Isolates in Four Geographic Regions, Lead author: Jones RN, presented at 12th annual Western Pacific Congress of Chemotherapy and Infectious Diseases, December 2 – 5, 2010, Singapore
Comparative Evaluation of Oritavancin against Gram-positive Pathogens Worldwide (2009)
Comparative Evaluation of Oritavancin against Gram-positive Pathogens Worldwide (2009), Lead author: Jones RN, presented at 12th annual Western Pacific Congress of Chemotherapy and Infectious Diseases, December 2 – 5, 2010, Singapore
Assessment of Tigecycline Activity against a Worldwide Collection of S. epidermidis, including Strains with Linezolid Resistance Mechanisms
Assessment of Tigecycline Activity against a Worldwide Collection of S. epidermidis, including Strains with Linezolid Resistance Mechanisms, Lead author: Jones RN, presented at 12th annual Western Pacific Congress of Chemotherapy and Infectious Diseases, December 2 – 5, 2010, Singapore
Impact of Revised CLSI and Current EUCAST Carbapenem (CARB) Breakpoints on Enterobacteriaceae (ENT) Susceptibility (S) Rates: Report from SENTRY Program
Impact of Revised CLSI and Current EUCAST Carbapenem (CARB) Breakpoints on Enterobacteriaceae (ENT) Susceptibility (S) Rates: Report from SENTRY Program, Lead author: Jones RN, presented at 12th annual Western Pacific Congress of Chemotherapy and Infectious Diseases, December 2 – 5, 2010, Singapore
Antimicrobial Susceptibility of Daptomycin and Comparator Agents Tested against Methicillin-Resistant S. aureus (MRSA) and Vancomycin-Resistant Enterococci (VRE): Analysis of a Five-Year Trend in USA Medical Centres (2005-2009)
Antimicrobial Susceptibility of Daptomycin and Comparator Agents Tested against Methicillin-Resistant S. aureus (MRSA) and Vancomycin-Resistant Enterococci (VRE): Analysis of a Five-Year Trend in USA Medical Centres (2005-2009), Lead author: Sader HS, presented at 48th annual Infectious Diseases Society of America (IDSA), October 21 – 24, 2010, Vancouver, Canada
Mutations Associated with Ketolide Resistance in S. Pneumoniae Collected in the 2009 SENTRY Antimicrobial Surveillance Program
Mutations Associated with Ketolide Resistance in S. Pneumoniae Collected in the 2009 SENTRY Antimicrobial Surveillance Program, Lead author: Farrell DJ, presented at 48th annual Infectious Diseases Society of America (IDSA), October 21 – 24, 2010, Vancouver, Canada
Experience with Linezolid in Vitro Coverage (% Susceptible) of S. aureus Pneumonia Isolates: Report From the SENTRY Antimicrobial Surveillance Program (1998-2009)
Experience with Linezolid in Vitro Coverage (% Susceptible) of S. aureus Pneumonia Isolates: Report From the SENTRY Antimicrobial Surveillance Program (1998-2009), Lead author: Jones RN, presented at 48th annual Infectious Diseases Society of America (IDSA), October 21 – 24, 2010, Vancouver, Canada
Summary of 2009 Oxazolidinone Resistance (R) Surveillance Studies Worldwide (LEADER and ZAAPS Programs)
Summary of 2009 Oxazolidinone Resistance (R) Surveillance Studies Worldwide (LEADER and ZAAPS Programs), Lead author: Jones RN, presented at 48th annual Infectious Diseases Society of America (IDSA), October 21 – 24, 2010, Vancouver, Canada
Linezolid Resistance Mechanisms Among Staphylococci and Enterococci Collected From Global Resistance Surveillance Programs
Linezolid Resistance Mechanisms Among Staphylococci and Enterococci Collected From Global Resistance Surveillance Programs, Lead author: Mendes RE, presented at 48th annual Infectious Diseases Society of America (IDSA), October 21 – 24, 2010, Vancouver, Canada
Tigecycline Activity against Multidrug-Resistant Enterobacteriaceae and Acinetobacter Spp. Isolated in USA Hospitals (2005-2009)
Tigecycline Activity against Multidrug-Resistant Enterobacteriaceae and Acinetobacter Spp. Isolated in USA Hospitals (2005-2009), Lead author: Sader HS, presented at 48th annual Infectious Diseases Society of America (IDSA), October 21 – 24, 2010, Vancouver, Canada
Species Distribution and Frequency of Antifungal Resistance (R) Variations Among Candida Bloodstream Infections (BSI) Isolates by Patient Age: Report From the SENTRY Program
Species Distribution and Frequency of Antifungal Resistance (R) Variations Among Candida Bloodstream Infections (BSI) Isolates by Patient Age: Report From the SENTRY Program, Lead author: Pfaller MA, presented at 48th annual Infectious Diseases Society of America (IDSA), October 21 – 24, 2010, Vancouver, Canada
Candida Bloodstream Infection (CBI): Comparison of Species Distribution and Resistance to Micafungin (MCF) and Azole Antifungal Agents in Intensive Care Unit (ICU) and Non-ICU Settings
Candida Bloodstream Infection (CBI): Comparison of Species Distribution and Resistance to Micafungin (MCF) and Azole Antifungal Agents in Intensive Care Unit (ICU) and Non-ICU Settings, Lead author: Pfaller MA, presented at 48th annual Infectious Diseases Society of America (IDSA), October 21 – 24, 2010, Vancouver, Canada
JNJ-Q2: a New Fluoroquinolone with Potent In Vitro Activity Against Staphylococcus aureus, Including Methicillin- and Fluoroquinolone-Resistant Strains
JNJ-Q2: a New Fluoroquinolone with Potent In Vitro Activity Against Staphylococcus aureus, Including Methicillin- and Fluoroquinolone-Resistant Strains, Lead author: Farrell DJ, presented at 48th annual Infectious Diseases Society of America (IDSA), October 21 – 24, 2010, Vancouver, Canada
Impact Assessment of Revised CLSI Cephalosporin Breakpoints (M100-S20, 2010) Using 27,415 Enterobacteriaceae Isolates Tested in the SENTRY Antimicrobial Surveillance Program
Impact Assessment of Revised CLSI Cephalosporin Breakpoints (M100-S20, 2010) Using 27,415 Enterobacteriaceae Isolates Tested in the SENTRY Antimicrobial Surveillance Program, Lead author: Rhomberg PR, presented at 48th annual Infectious Diseases Society of America (IDSA), October 21 – 24, 2010, Vancouver, Canada
Ceftaroline Activity Tested against Common Organisms Causing Skin and Skin-Structure Infections in USA Medical Centers During 2009
Ceftaroline Activity Tested against Common Organisms Causing Skin and Skin-Structure Infections in USA Medical Centers During 2009, Lead author: Sader HS, presented at 48th annual Infectious Diseases Society of America (IDSA), October 21 – 24, 2010, Vancouver, Canada
Ceftaroline Activity When Tested against Respiratory Tract Infection (RTI) Pathogens Isolated From USA Medical Centers in 2009
Ceftaroline Activity When Tested against Respiratory Tract Infection (RTI) Pathogens Isolated From USA Medical Centers in 2009, Lead author: Sader HS, presented at 48th annual Infectious Diseases Society of America (IDSA), October 21 – 24, 2010, Vancouver, Canada
Antimicrobial Activity of Ceftaroline Combined with NXL104 When Tested against Enterobacteriaceae Producing Derepressed AmpC β-Lactamase
Antimicrobial Activity of Ceftaroline Combined with NXL104 When Tested against Enterobacteriaceae Producing Derepressed AmpC β-Lactamase, Lead author: Sader HS, presented at 48th annual Infectious Diseases Society of America (IDSA), October 21 – 24, 2010, Vancouver, Canada
Worldwide Summary of Ceftobiprole Spectrum and Activity: Potencies against Enterobacteriaceae and Non-Fermentative Gram-Negative Bacilli (59,695 Isolates)
Worldwide Summary of Ceftobiprole Spectrum and Activity: Potencies against Enterobacteriaceae and Non-Fermentative Gram-Negative Bacilli (59,695 Isolates), Lead author: Farrell DJ, presented at 48th annual Infectious Diseases Society of America (IDSA), October 21 – 24, 2010, Vancouver, Canada
Worldwide Summary of Ceftobiprole Activity against 108,577 Gram-Positive Pathogens
Worldwide Summary of Ceftobiprole Activity against 108,577 Gram-Positive Pathogens, Lead author: Farrell DJ, presented at 48th annual Infectious Diseases Society of America (IDSA), October 21 – 24, 2010, Vancouver, Canada
Antimicrobial Activity of a New Fluoroketolide (CEM-101) Tested against Fastidious Gram-Negative Community-Acquired Bacterial Pneumonia (CABP) Pathogens
Antimicrobial Activity of a New Fluoroketolide (CEM-101) Tested against Fastidious Gram-Negative Community-Acquired Bacterial Pneumonia (CABP) Pathogens, Lead author: Biedenbach DJ, presented at 48th annual Infectious Diseases Society of America (IDSA), October 21 – 24, 2010, Vancouver, Canada
Antimicrobial Activity of a New Fluoroketolide (CEM-101) Tested against Streptococcus Pneumoniae Tested by the SENTRY Surveillance Program (2008-2009)
Antimicrobial Activity of a New Fluoroketolide (CEM-101) Tested against Streptococcus Pneumoniae Tested by the SENTRY Surveillance Program (2008-2009), Lead author: Biedenbach DJ, presented at 48th annual Infectious Diseases Society of America (IDSA), October 21 – 24, 2010, Vancouver, Canada
Evaluation of Oritavancin Antimicrobial Activity Tested against Staphylococcus aureus Associated with Skin and Skin-Structure Infections (2008 – 2009)
Evaluation of Oritavancin Antimicrobial Activity Tested against Staphylococcus aureus Associated with Skin and Skin-Structure Infections (2008 – 2009), Lead author: Mendes RE, presented at 48th annual Infectious Diseases Society of America (IDSA), October 21 – 24, 2010, Vancouver, Canada
Activity of Fusidic-Acid Tested against Contemporary Staphylococcus aureus Collected From United States Hospitals
Activity of Fusidic-Acid Tested against Contemporary Staphylococcus aureus Collected From United States Hospitals, Lead author: Castanheira M, presented at 48th annual Infectious Diseases Society of America (IDSA), October 21 – 24, 2010, Vancouver, Canada
Epidemiologic Characterization of Carbapenemase-Producing Enterobacteriaceae in India
Epidemiologic Characterization of Carbapenemase-Producing Enterobacteriaceae in India, Lead author: Mendes RE, presented at 48th annual Infectious Diseases Society of America (IDSA), October 21 – 24, 2010, Vancouver, Canada
Worldwide Summary of Doripenem Spectrum and Activity: Potencies against Non-Fermentative and Fastidious Gram-Negative Pathogens
Worldwide Summary of Doripenem Spectrum and Activity: Potencies against Non-Fermentative and Fastidious Gram-Negative Pathogens, Lead author: Farrell DJ, presented at 48th annual Infectious Diseases Society of America (IDSA), October 21 – 24, 2010, Vancouver, Canada
Worldwide Summary of Doripenem Spectrum and Activity: Potencies against Enterobacteriaceae (57,724 Isolates)
Worldwide Summary of Doripenem Spectrum and Activity: Potencies against Enterobacteriaceae (57,724 Isolates), Lead author: Farrell DJ, presented at 48th annual Infectious Diseases Society of America (IDSA), October 21 – 24, 2010, Vancouver, Canada
Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Evaluate Susceptibility Breakpoints (SB) for Labeled Cefepime Dosing Regimens
Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Evaluate Susceptibility Breakpoints (SB) for Labeled Cefepime Dosing Regimens, Lead author: Van Wart, presented at 50th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 12 – 15, 2010, Boston, MA
Pharmacokinetic-Pharmacodynamic (PK-PD) Basis for CLSI Carbapenem (CARB) Susceptibility Breakpoint Changes
Pharmacokinetic-Pharmacodynamic (PK-PD) Basis for CLSI Carbapenem (CARB) Susceptibility Breakpoint Changes, Lead author: Bhavnani SM, presented at 50th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 12 – 15, 2010, Boston, MA
Rare Occurrence of Retapamulin Resistance Mechanisms in Staphylococcus aureus Clinical Isolates: Report from the SENTRY Program
Rare Occurrence of Retapamulin Resistance Mechanisms in Staphylococcus aureus Clinical Isolates: Report from the SENTRY Program, Lead author: Mendes RE, presented at 50th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 12 – 15, 2010, Boston, MA
First Report of cfr-Carrying Staphylococcal Clinical Isolates in Mexico and Evidence of In Vivo cfr Mobilization
First Report of cfr-Carrying Staphylococcal Clinical Isolates in Mexico and Evidence of In Vivo cfr Mobilization, Lead author: Mendes RE, presented at 50th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 12 – 15, 2010, Boston, MA
Decreased-Linezolid Susceptibility Due to cfr in a Community-Associated Methicillin-Resistant Staphylococcus aureus (MRSA) Clone (USA300)
Decreased-Linezolid Susceptibility Due to cfr in a Community-Associated Methicillin-Resistant Staphylococcus aureus (MRSA) Clone (USA300), Lead author: Mendes RE, presented at 50th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 12 – 15, 2010, Boston, MA
Genetic Characterization and Comparative Antimicrobial Susceptibility of a New blaVIM-Variant
Genetic Characterization and Comparative Antimicrobial Susceptibility of a New blaVIM-Variant, Lead author: Mendes RE, presented at 50th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 12 – 15, 2010, Boston, MA
Oxa-163, an Oxa-48-Related Class D Beta-Lactamase with an Extended Activity to Expanded-Spectrum Cephalosporins
Oxa-163, an Oxa-48-Related Class D Beta-Lactamase with an Extended Activity to Expanded-Spectrum Cephalosporins, Lead author: Poirel, presented at 50th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 12 – 15, 2010, Boston, MA
Mechanisms of Resistance and Antimicrobial Susceptibility Profile of Carbapenem-Resistant Acinetobacter baumanii from P.R. China
Mechanisms of Resistance and Antimicrobial Susceptibility Profile of Carbapenem-Resistant Acinetobacter baumanii from P.R. China, Lead author: Wang, presented at 50th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 12 – 15, 2010, Boston, MA
Genetic Characterization of blaKPC-2-Carrying Klebsiella pneumoniae Collected from P.R. China During the 2009 SENTRY Antimicrobial Surveillance Program
Genetic Characterization of blaKPC-2-Carrying Klebsiella pneumoniae Collected from P.R. China During the 2009 SENTRY Antimicrobial Surveillance Program, Lead author: Wang, presented at 50th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 12 – 15, 2010, Boston, MA
Reduced Susceptibility to Extended-Spectrum Cephalosporins (ESCRS) in Neisseria gonorrhoeae from Ontario, Canada
Reduced Susceptibility to Extended-Spectrum Cephalosporins (ESCRS) in Neisseria gonorrhoeae from Ontario, Canada, Lead author: Melano, presented at 50th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 12 – 15, 2010, Boston, MA
Plasmid-Borne vga(A)-Encoding Gene in Methicillin-Resistant Staphylococcus aureus (MRSA) ST-398 from Swine and Swine Farmer in the United States
Plasmid-Borne vga(A)-Encoding Gene in Methicillin-Resistant Staphylococcus aureus (MRSA) ST-398 from Swine and Swine Farmer in the United States, Lead author: Mendes RE, presented at 50th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 12 – 15, 2010, Boston, MA
IS21-558 Insertion Sequences Associated with cfr Dissemination in S. epidermidis and S. aureus Recovered from two Medical Facilities in Ohio
IS21-558 Insertion Sequences Associated with cfr Dissemination in S. epidermidis and S. aureus Recovered from two Medical Facilities in Ohio, Lead author: Mendes RE, presented at 50th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 12 – 15, 2010, Boston, MA
Extended-Spectrum β-Lactamases (ESBLs) and Serine Carbapenemases in Pseudomonas aeruginosa from the Asia-Pacific Region: Report from the SENTRY Surveillance Program
Extended-Spectrum β-Lactamases (ESBLs) and Serine Carbapenemases in Pseudomonas aeruginosa from the Asia-Pacific Region: Report from the SENTRY Surveillance Program, Lead author: Bell JM, presented at 50th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 12 – 15, 2010, Boston, MA
Emergence of GES-Type ESBLs in Pseudomonas aeruginosa in Indian Hospitals
Emergence of GES-Type ESBLs in Pseudomonas aeruginosa in Indian Hospitals, Lead author: Bell JM, presented at 50th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 12 – 15, 2010, Boston, MA
Dissemination of NDM-1-producing Enterobacteriaceae in India
Dissemination of NDM-1-producing Enterobacteriaceae in India, Lead author: Mendes RE, presented at 50th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 12 – 15, 2010, Boston, MA
